Search Within

Taha Merghoub

  1. "Sloan Kettering Institute Faculty"
Formats
  1. Meeting Abstract (48)
  2. Journal Article (45)
  3. Book Section (2)
Groups
  1. Department of Medicine (95)
  2. Melanoma and Immunotherapeutics Service (95)
  3. Sloan Kettering Institute Faculty (95)
  4. Solid Tumor Oncology Division (95)
  5. GSK Faculty (93)
  6. Sloan Kettering Institute Postdocs (64)

More Groups

People
  1. Jedd Wolchok (69)
  2. Alan Houghton (45)
  3. Daniel Hirschhorn Cymerman (22)
  4. Liang Deng (21)
  5. Stewart Shuman (20)
  6. Peihong Dai (18)

More People

Years
  1. 2023 (2)
  2. 2022 (9)
  3. 2021 (4)
  4. 2020 (4)
  5. 2019 (2)
  6. 2018 (5)

More Years

Publications
  1. Cancer Research (15)
  2. Journal of Investigative Dermatology (11)
  3. Journal for ImmunoTherapy of Cancer (10)
  4. Blood (7)
  5. Cancer Immunology Research (5)
  6. Journal of Immunology (5)

More Publications

Publishers
  1. American Association for Cancer Research (22)
  2. Elsevier Science, Inc. (11)
  3. Biomed Central Ltd (10)
  4. American Society of Hematology (7)
  5. Nature Publishing Group (6)
  6. Public Library of Science (6)

More Publishers

Results (95)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of tumor metabolism on the microenvironment and response to immunotherapy
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Brunschvig, S.; Santhella, A.; Mane, M.; Vemuri, K.; Ijoma, J.; Kang, W.; Manovatodorova, K.; Koutcher, J.; more...
    Cancer Science (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • LDH inhibition improves response to CTLA-4 blockade by enhancing effector T cell activity and impairing regulatory T cell suppression
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Mangarin, L.; Ko, M.; Blasberg, R.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immune checkpoint blockade enhances cyclophosphamide induced anti-tumor immunity in a preclinical melanoma model
    Meeting Abstract

    George, M.; Betof, A.; Merghoub, T.; Hamadene, L.; Hirschhorn, D.; Houghton, A.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Deferiprone alters macrophage function and metabolism
    Meeting Abstract

    Ackerstaff, E.; Budhu, S.; Winkleman, D. P.; Min, S. S.; Ijoma, J. N.; Serganova, I. S.; Blasberg, R. G.; Merghoub, T.; Koutcher, J. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Combination of cyclophosphamide with immune checkpoint blockade inhibition elicits potent tumor control in a preclinical melanoma model
    Meeting Abstract

    George, M. M.; Warner, A. B.; Hamadene, L.; Hirschhorn, D.; Houghton, A. N.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Activating canonical p53 functions in tumor-associated macrophages improves immune checkpoint blockade efficacy
    Meeting Abstract

    Ghosh, A.; Michel, J.; Venkatesh, D.; Mezzadra, R.; Dong, L.; Samaan, F.; Gomez, R.; Suek, N.; Holland, A.; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Reprogramming the tumor microenvironment by a second-generation recombinant modified vaccinia virus Ankara
    Meeting Abstract

    Liu, S.; Mazo, G.; Yang, N.; Zhang, T.; Tariq, S. B.; Wang, Y.; Hirschhorn-Cymerman, D.; Ji, L.; Tan, A.; Wang, J.; more...
    Journal of Investigative Dermatology (2022)

    Fulltext@MSK | Save
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save